CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER

Cstone Announced New Drug Approval Of Cejemly® (sugemalimab) In China To Potentially Reshape The Landscape Of Immuno Oncology Therapy In Lung Cancer

Facebook Comments

Leave a Reply

CommentLuv badge